Miller Financial Services’s Cartesian Therapeutics RNAC Stock Holding History

Miller Financial Services’s Portfolio RNAC Stock Details RNAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$159K	Sell	22,110 -33	-0.1%	-$287	0.12%	135
2026 Q2	$231K	Hold	22,143	–	–	0.19%	120
2026 Q1	$136K	Buy	22,143 +8,500	+62%	+$60.6K	0.15%	110
2025 Q4	$98.4K	Buy	13,643 +2,000	+17%	+$16.2K	0.12%	109
2025 Q3	$119K	Hold	11,643	–	–	0.14%	109
2025 Q2	$121K	Buy	+11,643	New	+$124K	0.15%	104

Other funds holding RNAC

Fedenia Advisers Madison, Wisconsin $425M AUM 89.76% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.95B AUM 25.45% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Miller Financial Services's RNAC Position: Q3 2026 in Review

Miller Financial Services reduced its Cartesian Therapeutics (RNAC) stake by 0.15% in Q3 2026, selling an estimated $287 and leaving 22,110 shares worth $159K. The position accounts for 0.12% of the portfolio, ranked #135.

Miller Financial Services first reported a position in RNAC in Q2 2025 and has held it in 6 quarters since. The position peaked at $231K in Q2 2026. 12 funds tracked by Wall St. Rank hold RNAC as of Q3 2026.

Miller Financial Services held 22,110 shares of Cartesian Therapeutics worth $159K as of Q3 2026.
Miller Financial Services sold 33 Cartesian Therapeutics shares in Q3 2026, an estimated $287.
Cartesian Therapeutics made up 0.12% of Miller Financial Services's portfolio in Q3 2026, its #135 holding.
Miller Financial Services first reported a position in Cartesian Therapeutics in Q2 2025 and has held it in 6 quarters since.
Miller Financial Services's Cartesian Therapeutics position peaked at $231K in Q2 2026.
12 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2026.

Based on Miller Financial Services's 13F filing for Q3 2026, filed 20 Oct 2026.